COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT03143049
Brief Title: Pomalidomide-Cyclophosphamide-Dexamethasone (PCD) Versus Pomalidomide-Dexamethasone (PD) in Relapse or Refractory Myeloma

First Submitted : April 13, 2017
First Submitted that Met QC Criteria : May 3, 2017
First Posted : May 8, 2017

Last Update Submitted that Met QC Criteria : November 1, 2017
Last Update Posted : November 6, 2017